Up to 50% of patients with hepatitis C virus (HCV) infection have elevated cryoglobulin levels, but only 2-3% develop vasculiticsymptoms of HCV-related mixed cryoglobulinemia (HCV-MC). The recently introduced direct antiviral agents (DAA) have yielded high rates of sustainable viral response in chronic HCV infection, even in chronic kidney disease patients. The RENALCRYOGLOBULINEMIC observational multicentre cohort […]
The new GlomCon/ERA-EDTA roundtable discussion is scheduled tomorrow, February 14, 2020 at 5 pm CET, 4 pm GMT and 8 am PST. Dr Rianne Boenink will discuss on “Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy”. The moderator will be Dr Sokratis Stoumpos and the panelists will be Prof Kitty J. […]
https://www.era-edta.org/en/wp-content/uploads/2020/02/EQSUPh4VUAAOEr4.jpeg10802160ERA-EDTAERA-EDTA2020-02-10 09:24:022020-02-10 09:24:22New GlomCon/ERA-EDTA Webinar on "Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy"!
The webcast of the CTDay (Clinical Transplantation Day), held on November 29,2019 in Barcelona (Spain), is available on the ERA-EDTA website. The access to the webcast is for healthcare professionals only. View the webcast https://www.era-edta.org/en/virtual-meeting/#!resourcegroups/event_ids=253&page=1
https://www.era-edta.org/en/wp-content/uploads/2020/02/CTDay2019_banner500X250.png250508ERA-EDTAERA-EDTA2020-02-06 10:28:232020-02-06 10:37:22Did you miss the CTDay2019? View the webcast!
Both malnutrition and obesity are important problems in children with chronic kidney disease (CKD). The latest recommendations from the Pediatric Renal Nutrition Taskforce wererecently published to help guide nutritional recommendations for children with CKD stages 2–5 and those on dialysis. They emphasize the importance of breastfeeding or feeding with breastmilk for infants with CKD. The […]
Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are increased in inflammation and have been associated with endothelial dysfunction and cardiovascular risk. Patients with nephrotic syndrome (NS) show signs of endothelial dysfunction and so suPAR levels were evaluated in 152 patients with idopathic NS due to minimal change disease, focal segmental glomerulosclerosis or membranous […]
https://www.era-edta.org/en/wp-content/uploads/2020/02/sfz173f1.png46004000ERA-EDTAERA-EDTA2020-02-05 08:09:162020-02-05 08:09:16Soluble urokinase-type plasminogen activator receptor levels are independent of primary cause of idiopathic nephritic syndrome
The newest results from the prospective cohort Dialysis Outcomes and Practice Patterns Study (DOPPS) in the Gulf Cooperation Council (GCC) describe Kt/V achievement, its predictors and its relationship with mortality. The analysis included 1544 patients aged ≥18 years dialyzed for at least 180 days in Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab […]
https://www.era-edta.org/en/wp-content/uploads/2020/02/sfz195f1.png13902620ERA-EDTAERA-EDTA2020-02-03 20:56:452020-02-03 20:56:45Results from the 2012-18 DOPPS in the Gulf Cooperation Council countries now available
Pre-emptive transplantation is the optimum renal replacement therapy in terms of increasing life expectancy, improving quality of life and achieving the highest cost-effectiveness. Planning for the procedure requires an understanding of the following technical preconditions for successful transplant surgery: arterial and venous factors, urinary drainage, organ and recipient factors. Vasculature should be carefully evaluated in […]
https://www.era-edta.org/en/wp-content/uploads/2020/02/m_gfz253f1.jpg238520ERA-EDTAERA-EDTA2020-02-03 11:31:182020-02-03 11:31:18What should a nephrologist know about surgical assessment of potential renal transplant recipients?
Hypertension is both a major cause and consequence of chronic kidney disease (CKD). It is associated with increased risk of cardiac events, stroke and kidney disease progression. The latest National Kidney Foundation Clinical Practice Guidelines recommend a blood pressure goal of <130mmHg systolic and <80mmHg diastolic for all CKD patients, regardless of the level of […]
https://www.era-edta.org/en/wp-content/uploads/2019/10/patient_img_home.jpg7001000ERA-EDTAERA-EDTA2020-01-31 11:36:442020-01-31 11:36:44Clinical considerations and strategies for treating hypertension in CKD patients
Vitamin K naturally occurs as type 1, which predominantly activates hepatic, i.e. coagulation-relevant vitamin K-dependent proteins (VKDPs), and type 2, activating the extra-hepatic VKDPs, including the Matrix gla protein (MGP) and osteocalcin. The latter VKDPs seem to be involved in the prevention of ectopic mineralization, thus contributing to cardiovascular disease prevention. Patients with chronic kidney […]
https://www.era-edta.org/en/wp-content/uploads/2020/01/m_gfz291f1_rid.png321513ERA-EDTAERA-EDTA2020-01-30 09:11:262020-01-30 09:11:26Vitamin K supplementation protects kidneys and heart
Patients with advanced chronic kidney disease (CKD) suffer from a wide range of symptoms influencing their quality of life, morbidity and mortality rates. In order to provide better insight into the association between kidney function decline and symptom development in elderly patients with advanced CKD (eGFR ≤20mL/min/1.73m2) a prospective European Quality study on treatment in […]
https://www.era-edta.org/en/wp-content/uploads/2020/01/m_gfz277f3.png322520ERA-EDTAERA-EDTA2020-01-29 10:10:212020-01-29 10:10:21The EQUAL study reports an association between kidney function decline and symptom development
Direct-acting antiviral agents improve kidney survival in hepatitis C virus-associated cryoglobulinemia
News, News-HomeUp to 50% of patients with hepatitis C virus (HCV) infection have elevated cryoglobulin levels, but only 2-3% develop vasculiticsymptoms of HCV-related mixed cryoglobulinemia (HCV-MC). The recently introduced direct antiviral agents (DAA) have yielded high rates of sustainable viral response in chronic HCV infection, even in chronic kidney disease patients. The RENALCRYOGLOBULINEMIC observational multicentre cohort […]
New GlomCon/ERA-EDTA Webinar on “Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy”!
News, News-HomeThe new GlomCon/ERA-EDTA roundtable discussion is scheduled tomorrow, February 14, 2020 at 5 pm CET, 4 pm GMT and 8 am PST. Dr Rianne Boenink will discuss on “Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy”. The moderator will be Dr Sokratis Stoumpos and the panelists will be Prof Kitty J. […]
Did you miss the CTDay2019? View the webcast!
News, News-HomeThe webcast of the CTDay (Clinical Transplantation Day), held on November 29,2019 in Barcelona (Spain), is available on the ERA-EDTA website. The access to the webcast is for healthcare professionals only. View the webcast https://www.era-edta.org/en/virtual-meeting/#!resourcegroups/event_ids=253&page=1
The newest recommendations from the Pediatric Renal Nutrition Taskforce
News, News-HomeBoth malnutrition and obesity are important problems in children with chronic kidney disease (CKD). The latest recommendations from the Pediatric Renal Nutrition Taskforce wererecently published to help guide nutritional recommendations for children with CKD stages 2–5 and those on dialysis. They emphasize the importance of breastfeeding or feeding with breastmilk for infants with CKD. The […]
Soluble urokinase-type plasminogen activator receptor levels are independent of primary cause of idiopathic nephritic syndrome
News, News-HomeSerum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are increased in inflammation and have been associated with endothelial dysfunction and cardiovascular risk. Patients with nephrotic syndrome (NS) show signs of endothelial dysfunction and so suPAR levels were evaluated in 152 patients with idopathic NS due to minimal change disease, focal segmental glomerulosclerosis or membranous […]
Results from the 2012-18 DOPPS in the Gulf Cooperation Council countries now available
News, News-HomeThe newest results from the prospective cohort Dialysis Outcomes and Practice Patterns Study (DOPPS) in the Gulf Cooperation Council (GCC) describe Kt/V achievement, its predictors and its relationship with mortality. The analysis included 1544 patients aged ≥18 years dialyzed for at least 180 days in Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab […]
What should a nephrologist know about surgical assessment of potential renal transplant recipients?
News, News-HomePre-emptive transplantation is the optimum renal replacement therapy in terms of increasing life expectancy, improving quality of life and achieving the highest cost-effectiveness. Planning for the procedure requires an understanding of the following technical preconditions for successful transplant surgery: arterial and venous factors, urinary drainage, organ and recipient factors. Vasculature should be carefully evaluated in […]
Clinical considerations and strategies for treating hypertension in CKD patients
News, News-HomeHypertension is both a major cause and consequence of chronic kidney disease (CKD). It is associated with increased risk of cardiac events, stroke and kidney disease progression. The latest National Kidney Foundation Clinical Practice Guidelines recommend a blood pressure goal of <130mmHg systolic and <80mmHg diastolic for all CKD patients, regardless of the level of […]
Vitamin K supplementation protects kidneys and heart
News, News-HomeVitamin K naturally occurs as type 1, which predominantly activates hepatic, i.e. coagulation-relevant vitamin K-dependent proteins (VKDPs), and type 2, activating the extra-hepatic VKDPs, including the Matrix gla protein (MGP) and osteocalcin. The latter VKDPs seem to be involved in the prevention of ectopic mineralization, thus contributing to cardiovascular disease prevention. Patients with chronic kidney […]
The EQUAL study reports an association between kidney function decline and symptom development
News, News-HomePatients with advanced chronic kidney disease (CKD) suffer from a wide range of symptoms influencing their quality of life, morbidity and mortality rates. In order to provide better insight into the association between kidney function decline and symptom development in elderly patients with advanced CKD (eGFR ≤20mL/min/1.73m2) a prospective European Quality study on treatment in […]